Default company panoramic image
9ae349b8 1d13 4300 a5f1 1f717b3f6f8e

Recombinetics, Inc. (RCI)

Transforming Public Health by Engineering Animals for Biomedicine & Food Production .

  • Stage Product In Development
  • Industry Biotechnology
  • Location St Paul, MN, USA
  • Currency USD
  • Founded August 2008
  • Employees 9
  • Website

Company Summary

Recombinetics has developed and acquired a portfolio of proprietary genome engineering technologies it uses to make precise modifications to the genomes of several livestock species. The results are animals with enhanced value for biomedicine and agricultural markets. First products are pigs that exhibit human heart disease. Customers are academic scientists, pharmaceutical and medical device companies, and CROs that want a consistent model.


  • Default avatar
    Scott Fahrenkrug
    CEO & Chairman

  • Default avatar
    Mark Walton
    CMO (Chief Marketing Officer)

  • Default avatar
    Perry Hackett
    CSO (Chief Scientific Officer)

  • Default avatar
    Justin Zenanko

  • Default avatar
    Cliff Steer
    CMO (Chief Medical Officer)


  • Default avatar
    General: Cameron Law Office, Business: Larkin & Hoffman, IP: Dardi & Herbert, LLP
    Default avatar
    Audits: Olsen Thielen, Taxation & General: Deloitte Touche

Previous Investors

  • Default avatar
    Founders, Friends and Family